|
|
|||
|
||||
OverviewThis text presents a collection of articles that represent individual and expert perspectives in both preclinical and clinical development, including case studies on real-life examples of successful drugs that add value to the pharmacokinetic principles learned and applied. Unlike existing books that focus on pharmacokinetic theory, the current book emphasizes application of pharmacokinetic principles in new drug development. Full Product DetailsAuthor: Rajesh KrishnaPublisher: Springer Science+Business Media Imprint: Kluwer Academic/Plenum Publishers Edition: 2004 ed. Dimensions: Width: 17.80cm , Height: 4.00cm , Length: 25.40cm Weight: 1.256kg ISBN: 9780306477669ISBN 10: 0306477661 Pages: 550 Publication Date: 31 October 2003 Audience: College/higher education , Professional and scholarly , Undergraduate , Postgraduate, Research & Scholarly Format: Hardback Publisher's Status: Active Availability: Out of stock The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available. Table of Contents1. Efficient and Effective Drug Development; W.A. Colburn, G. Heath. 2. Bioanalytical Methods: Challenges and Opportunities in Drug Development; M.L. Powell, S.E. Unger. 3. Prediciting Human Oral Bioavalibility using In Silico Models; L. X. Yu, et al. 4. Drug Metabolism in Preclinical Development; M.W. Sinz. 5. Interspecies Scaling; T. Lavé, et al. 6. Human Drug Absorption Studies in Early Development; D.V. Prior, et al. 7. Food-Drug Interactions: Drug Development Considerations; D. Fleisher, L. Reynolds. 8. Global Regulatory and Biopharmaceutics Strategies in New Drug Development: Biowaivers; E. Gupta, E. Yamashita. 9. Special Population Studies in Clinical Development: Pharmacokinetic Considerations; J.M. Kovarik. 10. Drug-Drug Interactions; S.M. Huang. 11. Pharmacokinetic/Pharmacodynamic Modeling in Drug Development; S. Rohatagi, et al. 12. Population Pharmacokinetic and Pharmacodynamic Modeling; R. Jelliffe, et al. 13. Role of Preclinical Metabolism and Pharmacokinetics in the Development of Celecoxib; S.K. Paulson, T.J. Maziasz. 14. The Role of Clinical Pharmacology and of Pharmacokinetics in the Development of Alendronate - A Bone Resorption Inhibitor; A.G. Porras, B.J. Gertz. 15. Optimizing Individualized Dosage Regimens of Potentially Toxic Drugs; R.W. Jelliffe, et al. Appendix. Index.ReviewsPharmacokinetics and pharmacodynamics (PK/PD) have become essential disciplines in drug research and development. Rational use of PK/PD allows for better decision making and streamlines dose optimization. The present book gives an excellent overview of the state of the art of PK/PD in modern drug development. The book was prepared by a group of expert scientists with vast experience in the drug development process. It is full of real-life examples, and is well-structured and easy to follow. In particular, it provides an excellent link between the preclinical and clinical phases of drug development. This book is of great value to everybody working in the field of PK/PD. <br>(Hartmut Derendorf, Ph.D., F.C.P., Distinguished Professor and Chairman, Dept. of Pharmaceutics, University of Florida, Gainesville)<br> This is a superb book providing, to my knowledge, the best integration of the important principles of pharmacokinetics and pharmacodynamics with the FDA's regulatory policies in the development of drug products. It is not an academic approach, but rather a down to earth how to' which is loaded with actual examples that have passed FDA muster. This book belongs on the desk and nightstand of everyone involved in the drug development process. <br>(Jerome P. Skelly, Ph.D., F.C.P., Pharmaceutical Consultant and Professor of Biopharmaceutics College of Pharmacy, University of Cincinnati, OH) Pharmacokinetics and pharmacodynamics (PK/PD) have become essential disciplines in drug research and development. Rational use of PK/PD allows for better decision making and streamlines dose optimization. The present book gives an excellent overview of the state of the art of PK/PD in modern drug development. The book was prepared by a group of expert scientists with vast experience in the drug development process. It is full of real-life examples, and is well-structured and easy to follow. In particular, it provides an excellent link between the preclinical and clinical phases of drug development. This book is of great value to everybody working in the field of PK/PD. (Hartmut Derendorf, Ph.D., F.C.P., Distinguished Professor and Chairman, Dept. of Pharmaceutics, University of Florida, Gainesville) This is a superb book providing, to my knowledge, the best integration of the important principles of pharmacokinetics and pharmacodynamics with the FDA's regulatory policies in the development of drug products. It is not an academic approach, but rather a down to earth 'how to' which is loaded with actual examples that have passed FDA muster. This book belongs on the desk and nightstand of everyone involved in the drug development process. (Jerome P. Skelly, Ph.D., F.C.P., Pharmaceutical Consultant and Professor of Biopharmaceutics College of Pharmacy, University of Cincinnati, OH) Pharmacokinetics and pharmacodynamics (PK/PD) have become essential disciplines in drug research and development. Rational use of PK/PD allows for better decision making and streamlines dose optimization. The present book gives an excellent overview of the state of the art of PK/PD in modern drug development. The book was prepared by a group of expert scientists with vast experience in the drug development process. It is full of real-life examples, and is well-structured and easy to follow. In particular, it provides an excellent link between the preclinical and clinical phases of drug development. This book is of great value to everybody working in the field of PK/PD. (Hartmut Derendorf, Ph.D., F.C.P., Distinguished Professor and Chairman, Dept. of Pharmaceutics, University of Florida, Gainesville) This is a superb book providing, to my knowledge, the best integration of the important principles of pharmacokinetics and pharmacodynamics with the FDA's regulatory policies in the development of drug products. It is not an academic approach, but rather a down to earth 'how to' which is loaded with actual examples that have passed FDA muster. This book belongs on the desk and nightstand of everyone involved in the drug development process. (Jerome P. Skelly, Ph.D., F.C.P., Pharmaceutical Consultant and Professor of Biopharmaceutics College of Pharmacy, University of Cincinnati, OH) Author InformationTab Content 6Author Website:Countries AvailableAll regions |
||||